Chloroquine Use For COVID-19 Shows No Benefit In First Small—But Limited—Controlled Trial

A pharmacist shows a box of tablets called “Plaquenil”, on March 23, 2020, in Rennes, western Results from the first controlled study of hydroxychloroquine for treating COVID-19 showed no significant difference in outcomes between those who received the drug and those who received usual care. Hydroxychloroquine is one of […]

Click here to view original web page at